Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121042743 | 12104274 | 3 | F | 201602 | 20160707 | 20160223 | 20160712 | EXP | US-UNITED THERAPEUTICS-UNT-2016-002446 | UNITED THERAPEUTICS | 42.67 | YR | M | Y | 119.27000 | KG | 20160712 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121042743 | 12104274 | 1 | PS | TYVASO | TREPROSTINIL | 1 | 18-54 ?G, QID | U | U | 2100716 | 22387 | INHALATION GAS | QID | ||||||
121042743 | 12104274 | 2 | C | OPSUMIT | MACITENTAN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
121042743 | 12104274 | 1 | Pulmonary hypertension |
121042743 | 12104274 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
121042743 | 12104274 | HO |
121042743 | 12104274 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
121042743 | 12104274 | Chest pain | |
121042743 | 12104274 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
121042743 | 12104274 | 1 | 20151015 | 20160213 | 0 |